Small Cap
Are Dip Buyers Tapped Out After Friday?
There are plenty of stocks I want to buy now, but the action is dismal.
2 Major Themes Are Causing Significant Market Disruption
Now that rotational action between growth and value is picking up steam, the disparity between index and individual stock performance is even greater.
10 Top Picks in Fintech and Finance for 2022
Newsletter advisors this year are focused on smaller niche plays in private equity, business development, credit, mortgages, money transfers and fintech.
My Deep Value Active and Passive Portfolios Are Sucking Wind, But It's Early
The idea behind this experiment is my belief that companies trading at relatively low levels of NCAV have the potential to provide solid returns.
I'm on the Lookout for an Intraday Market Reversal
There are signs that a reversal may be brewing and many small-caps and biotechnology names are weak again.
Top Stock Picks for 2022 in Biotech and Genetics
Seven investment experts participating in Moneyshow's Top Picks 2022 report share their ideas for healthy portfolio gains in 2022.
Many Individual Stocks Have Been Buried in the Bear Market
A number of stocks are looking oversold in view of their longer-term prospects.
The Corrective Process Is Finally Hitting the Mega-Cap Leaders
What I'm looking for now is whether charts can find support.
2 Battered Biotech Stocks That Insiders Are Buying
Often this can signal a potential substantial turnaround in the shares.
How I'm Handling and Trading the Market's Rotational Action
The most significant difficulty is that it undermines stock-picking.